UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 163

Sortiert nach

Alteration of DNA mismatch repair capacity underlying the co-occurrence of non-small-cell lung cancer and nonmedullary thyroid cancer

Scientific reports, 2021-02, Vol.11 (1), p.3597-3597, Article 3597

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non‐small cell lung cancer

Cancer science, 2020-12, Vol.111 (12), p.4442-4452

2020

Link zum Volltext

Verfügbarkeit prüfen

Biological Difference between L858R and Exon 19 Deletion Contributes to Recurrence-Free Survival of Resected Non-Small Cell Lung Cancer

Oncology, 2023-02, Vol.101 (2), p.117-125

2023

Link zum Volltext

Verfügbarkeit prüfen

Sialadenoma papilliferum of the bronchus: focus on histological and genetic distinction from mixed squamous cell and glandular papilloma

Pathology, 2021-10, Vol.53 (6), p.788-790

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparison between Fluorimetry (Qubit) and Spectrophotometry (NanoDrop) in the Quantification of DNA and RNA Extracted from Frozen and FFPE Tissues from Lung Cancer Patients: A Real-World Use of Genomic Tests

Medicina (Kaunas, Lithuania), 2021-12, Vol.57 (12), p.1375

2021

Link zum Volltext

Verfügbarkeit prüfen

Negative reactions of BRAF mutation‐specific immunohistochemistry to non‐V600E mutations of BRAF

Pathology international, 2020-05, Vol.70 (5), p.253-261

2020

Link zum Volltext

Verfügbarkeit prüfen

Positive Correlation Between the Number of Circulating Tumor Cells in the Pulmonary Vein and Tumor Spread Through Air Spaces in Resected Non-small Cell Lung Cancer

Anticancer research, 2021-11, Vol.41 (11), p.5499-5505

2021

Link zum Volltext

Verfügbarkeit prüfen

Programmed death-ligand 1 expression and T790M status in EGFR-mutant non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2017-09, Vol.111, p.182-189

2017

Link zum Volltext

Verfügbarkeit prüfen

Biomarker testing for personalized, first-line therapy in advanced nonsquamous non-small cell lung cancer patients in the real world setting in Japan: a retrospective, multicenter, observational study (the BRAVE study)

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920904522-1758835920904522

2020

Link zum Volltext

Verfügbarkeit prüfen

Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck

The journal of pathology. Clinical research, 2020-04, Vol.6 (2), p.154-159

2020

Link zum Volltext

Verfügbarkeit prüfen

Calculating the Tumor Nuclei Content for Comprehensive Cancer Panel Testing

Journal of thoracic oncology, 2020-01, Vol.15 (1), p.130-137

2020

Link zum Volltext

Verfügbarkeit prüfen

ROS1 Immunohistochemistry Among Major Genotypes of Non–Small-Cell Lung Cancer

Clinical lung cancer, 2015-03, Vol.16 (2), p.106-111

2015

Link zum Volltext

Verfügbarkeit prüfen

Validation of the digital PCR system in tyrosine kinase inhibitor‐resistant EGFR mutant non‐small‐cell lung cancer

Pathology international, 2018-03, Vol.68 (3), p.167-173

2018

Link zum Volltext

Verfügbarkeit prüfen

Changes in serum DAMPs and cytokines/chemokines during near‐infrared photoimmunotherapy for patients with head and neck cancer

Cancer medicine (Malden, MA), 2024-01, Vol.13 (1), p.n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

Association of the KRAS genotype and clinicopathologic findings of resected non‐small‐cell lung cancer: A pooled analysis of 179 patients

Cancer genetics, 2022-11, Vol.268-269, p.64-74

2022

Link zum Volltext

Verfügbarkeit prüfen

Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations

BMC cancer, 2015-11, Vol.15 (907), p.908-908, Article 908

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical Guideline-Guided Outcome Consistency for Surgically Resected Stage III Non-Small Cell Lung Cancer: A Retrospective Study

Cancers, 2021-05, Vol.13 (11), p.2531

2021

Link zum Volltext

Verfügbarkeit prüfen

Optimal dilution of contrast medium for quantitating parenchymal blood volume using a flat-panel detector

Journal of international medical research, 2018-01, Vol.46 (1), p.464-474

2018

Link zum Volltext

Verfügbarkeit prüfen

Permissible Outcomes of Lobe-Specific Lymph Node Dissection for Elevated Carcinoembryonic Antigen in Non-Small Cell Lung Cancer

Medicina (Kaunas, Lithuania), 2021-12, Vol.57 (12), p.1365

2021

Link zum Volltext

Verfügbarkeit prüfen

Caspase-4 promotes metastasis and interferon-γ-induced pyroptosis in lung adenocarcinoma

Communications biology, 2024-06, Vol.7 (1), p.699-14, Article 699

2024

Link zum Volltext

Verfügbarkeit prüfen

New evaluation of the tumor immune microenvironment of non-small cell lung cancer and its association with prognosis

Journal for immunotherapy of cancer, 2022-04, Vol.10 (4), p.e003765

2022

Link zum Volltext

Verfügbarkeit prüfen

Multiple Primary Malignancies in Patients with Non-Small Cell Lung Cancer

Internal Medicine, 2015, Vol.54(3), pp.325-331

2015

Link zum Volltext

Verfügbarkeit prüfen

Effect of vascular endothelial growth factor polymorphisms on survival in advanced‐stage non‐small‐cell lung cancer

Cancer science, 2009-10, Vol.100 (10), p.1917-1922

2009

Link zum Volltext

Verfügbarkeit prüfen

Effect of Coronavirus Disease 2019 Vaccine-Related Lymphadenopathy on Lung Cancer Treatment

Journal of thoracic oncology, 2022-01, Vol.17 (1), p.16-18

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 163

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(135)
Mit Volltextzugriff
(158)

Publikationsform

Artikel
(153)
Berichte
(10)

Sprache

Englisch
(160)
Japanisch
(31)

Erscheinungsjahr

n.n

Thema

Science & Technology
(131)
Life Sciences & Biomedicine
(124)
Oncology
(92)
Humans
(84)
Aged
(58)
Female
(58)
Male
(58)
Middle Aged
(44)
Mutation
(39)
Lung Neoplasms - Drug Therapy
(38)
Aged, 80 And Over
(35)
Lung Neoplasms - Genetics
(34)
Lung Cancer
(32)
Lung Neoplasms - Pathology
(31)
Carcinoma, Non-Small-Cell Lung - Genetics
(30)
Adult
(28)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(28)
Non-Small Cell Lung Cancer
(28)
Tumors
(24)
Carcinoma, Non-Small-Cell Lung - Pathology
(22)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Alteration of DNA mismatch repair capacity underlying the co-occurrence of non-small-cell lung cancer and nonmedullary thyroid cancer

Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non‐small cell lung cancer

Biological Difference between L858R and Exon 19 Deletion Contributes to Recurrence-Free Survival of Resected Non-Small Cell Lung Cancer

Sialadenoma papilliferum of the bronchus: focus on histological and genetic distinction from mixed squamous cell and glandular papilloma

Comparison between Fluorimetry (Qubit) and Spectrophotometry (NanoDrop) in the Quantification of DNA and RNA Extracted from Frozen and FFPE Tissues from Lung Cancer Patients: A Real-World Use of Genomic Tests

Negative reactions of BRAF mutation‐specific immunohistochemistry to non‐V600E mutations of BRAF

Positive Correlation Between the Number of Circulating Tumor Cells in the Pulmonary Vein and Tumor Spread Through Air Spaces in Resected Non-small Cell Lung Cancer

Programmed death-ligand 1 expression and T790M status in EGFR-mutant non-small cell lung cancer

Biomarker testing for personalized, first-line therapy in advanced nonsquamous non-small cell lung cancer patients in the real world setting in Japan: a retrospective, multicenter, observational study (the BRAVE study)

Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck

Calculating the Tumor Nuclei Content for Comprehensive Cancer Panel Testing

ROS1 Immunohistochemistry Among Major Genotypes of Non–Small-Cell Lung Cancer

Validation of the digital PCR system in tyrosine kinase inhibitor‐resistant EGFR mutant non‐small‐cell lung cancer

Changes in serum DAMPs and cytokines/chemokines during near‐infrared photoimmunotherapy for patients with head and neck cancer

Association of the KRAS genotype and clinicopathologic findings of resected non‐small‐cell lung cancer: A pooled analysis of 179 patients

Candidate tumor-specific CD8 + T cell subsets identified in the malignant pleural effusion of advanced lung cancer patients by single-cell analysis

Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations

Clinical Guideline-Guided Outcome Consistency for Surgically Resected Stage III Non-Small Cell Lung Cancer: A Retrospective Study

Optimal dilution of contrast medium for quantitating parenchymal blood volume using a flat-panel detector

Permissible Outcomes of Lobe-Specific Lymph Node Dissection for Elevated Carcinoembryonic Antigen in Non-Small Cell Lung Cancer

Caspase-4 promotes metastasis and interferon-γ-induced pyroptosis in lung adenocarcinoma

New evaluation of the tumor immune microenvironment of non-small cell lung cancer and its association with prognosis

Multiple Primary Malignancies in Patients with Non-Small Cell Lung Cancer

Effect of vascular endothelial growth factor polymorphisms on survival in advanced‐stage non‐small‐cell lung cancer

Effect of Coronavirus Disease 2019 Vaccine-Related Lymphadenopathy on Lung Cancer Treatment

Suchergebnisse filtern